← Russell 3000 cross-section

AMWL American Well Corp

Trailing twelve months to 2026-06-30 · as filed 2026-08-04, not restated
Technology

Scale

Market cap
$198m
Revenue TTM
$218m
Net income TTM
$-78m
Free cash flow
$-26m
Composite score
28.1
Sector rank
#2876

Valuation

P / E
EV / EBITDA
EV / sales
0.0
FCF yield
-13.32%
Earnings yield vs 10-yr
-44.11pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-35.8%
EBITDA margin
-22.4%
ROE
-35.3%
ROIC
-322.4%
Revenue growth
-19.0%

Insider activity, last 90 days

Net open-market
$-0.41m
Buyers
0
Sellers
5

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Visits have declined in the current period due to lower urgent care and behavioral visits as a result of customer churn, combined with summer seasonality. The following table presents a reconciliation of adjusted EBITDA from the most comparable GAAP measure, net loss, for the three and six months ended June 30, 2026 and 2025: (1) Severance and strategic transformation costs include expenses associated with the termination of employees and expenses (including abandonment of our corporate headquarters) that focus on transforming the strategy of the Company’s sales and growth organization as well as our overall cost structure during the three and six months ended June 30, 2026 and 2025. …American Well Corp, 10-Q, period ended 2026-06-30, filed 2026-08-04

Read the full passage →